Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/22/2003US20030096859 Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096782 Expression profiling in the intact human heart
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096755 Suppression of inhibitors
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096733 Novel drug targets for arthritis
05/22/2003US20030096434 Multi-purpose optical analysis optical bio-disc for conducting assays and various reporting agents for use therewith
05/22/2003US20030096432 Detection of modulators of ligand binding activity; obtain sample containing ligand receptor, mix with mixture containing ligand and test modulator, monitor adjustment in ligand binding
05/22/2003US20030096428 Sampler for dust on surfaces
05/22/2003US20030096427 Multiwell apparatus
05/22/2003US20030096424 Sintered polymer membrane for analyte detection device
05/22/2003US20030096422 Solvent extraction of particles from sample; obtain sample, incubate with solvent, control pressure, extract particles
05/22/2003US20030096420 Instrument
05/22/2003US20030096419 Monitoring fluid in air conditioning or refrigeration apparatus; prepare nonradioactive label, mix with air conditioning or refrigeration fluid, analyze, determine adjustments in fluids
05/22/2003US20030096418 Preparation of solid support for use in the detection of particle in lipid layers; provide substrate, immerse in suspension, transfer to solid support, establish bulk aqueous phase above solid support, detect particle in solution
05/22/2003US20030096404 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
05/22/2003US20030096401 Eukaryotic expression libraries and methods of use
05/22/2003US20030096395 Device for motile sperm separation
05/22/2003US20030096389 Composition for use as diagnostic tool in test kit
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease
05/22/2003US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096332 Stabilized tetrazolium reagent compositions and methods for using the same
05/22/2003US20030096331 Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
05/22/2003US20030096329 (1-3)-beta-D-glucan binding domain protein, measuring method using the substance and assay kit
05/22/2003US20030096327 Detection of tumor disorder in humans; obtain tissue sample, screen for presence of tumor marker, presence of marker indicates tumor disorder
05/22/2003US20030096325 Evaluating human sensitivity to antitumor agents; obtain blood sample, monitor blood glutathione concentration, amplified concentration indicates sensitivity to antitumor agents
05/22/2003US20030096324 Counting cells; obtain cells, deposit on slide, visualize cells, count cells
05/22/2003US20030096323 Detecting phosphodiesterase inhibitor; obtain cell, incubate with modulator, monitor expression of cyclic adenine and guanine monophosphates, compare to control, reduction in concentrations indicate inhibitor
05/22/2003US20030096322 System for cell-based screening
05/22/2003US20030096321 Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips
05/22/2003US20030096319 Method of sorting birds
05/22/2003US20030096318 Detection of cell preferential protein expression; obtain cells, monitor protein expression pattern, compare to control, detect expression of unique proteins
05/22/2003US20030096316 Use of apolipoprotein B as a single marker for evaluation of the risk or cardiovascular disease
05/22/2003US20030096313 Novel serine-threonine kinase-4
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096311 Detection of allergic response in humans; obtain interferon sample, incubate wot test agent, detect conjugation between interferon and agent, conjugation indicates induction of allergies
05/22/2003US20030096309 Screening system for identifying drug-drug interactions and methods of use thereof
05/22/2003US20030096308 Peptide sequence tags and method of using same
05/22/2003US20030096307 Functional site profiles for proteins and methods of making and using the same
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096304 Nuclear matrix protein fluid assay
05/22/2003US20030096302 Detection of preferential particles in sample: obtain sample, expose sample to light, monitor sample response to light
05/22/2003US20030096301 Linker for solid-phase synthesis
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096298 Detection of peptides associated with preferential cells; obtain cells expressing major histocompatibility complex, recover compelex, analyze peptides bound to complex, recover and classify peptides
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
05/22/2003US20030096294 Automated method for setting up crystallization experiments employing a crystallization device identification code reader
05/22/2003US20030096293 Automated crystallization experiment setup apparatus comprising crystallization device identification code reader
05/22/2003US20030096292 Method of making high density arrays
05/22/2003US20030096290 Methods for cancer prognosis and diagnosis
05/22/2003US20030096289 Oligonucleotide-immobilized substrate for detecting methylation
05/22/2003US20030096288 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
05/22/2003US20030096285 Detection of targets for anticarcinogenic agents; obtain tumor cells, determine protein expression pattern, compare to wild type, isolate differentially expessed proteins, use protein as diagnostic tool
05/22/2003US20030096283 Electrochemical detection of single base extension
05/22/2003US20030096282 Gtpase-activating protein 1
05/22/2003US20030096275 Kit for the detection of preferential particles in sample
05/22/2003US20030096273 Methods for immobilizing molecules to a solid phase and uses thereof
05/22/2003US20030096271 Full-length serine protein kinase in brain and pancreas
05/22/2003US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
05/22/2003US20030096267 Essential bacterial genes and their use
05/22/2003US20030096265 The formed probe for use in a microarray analysis to bond covalently to a hydrogel; solid phase synthsis
05/22/2003US20030096264 Screening sequences for genotypes which is sensitive to nervous system treatments; obtain sequences, screen for preferential genotype, presence of preferential genotype indicates candidate for treatment of nervous system disorders
05/22/2003US20030096263 Detection of enzyme inhibitors; obtain sample containing enzyme of interest, incubate with modulator, detect adjustment in enzyme activity, reduction in activity indicates enzyme inhibitor
05/22/2003US20030096261 Determining gene expression profile of vascular endothelial cells; obtain cells, incubate with immunological agent, isolate bound cells, extract ribonucleic acid sequences, expose to probe, monitor expression profile
05/22/2003US20030096253 Single nucleotide amplification and detection by polymerase
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096245 Invasive cleavage of nucleic acids
05/22/2003US20030096244 Diagnosis of parasitic infections; obtain sample, extract nucleotide sequences, incubate with primer, amplify sequences, separate products, incubate with probes and detect signal, presence of signal indicates presence of parasite
05/22/2003US20030096243 Measurement of gene expression in target cells; provide genetically engineered cells which express labeled nucleotide sequences, scanning the cells to obtain fluorescent signals, determine concentration of nucleotide sequences
05/22/2003US20030096241 Method of testing squamous epithelial cells
05/22/2003US20030096238 Compositions and methods relating to gynecologic cancer specific genes
05/22/2003US20030096237 Determination of the ability of patients to respond to a tumor treatment
05/22/2003US20030096235 Complexity management of genomic DNA
05/22/2003US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096232 High throughput assay system
05/22/2003US20030096227 Kit for use in the diagnosis of alzheimer's disease
05/22/2003US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
05/22/2003US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein
05/22/2003US20030096224 Retentate chromatography and protein chip arrays with applications in biology and medicine
05/22/2003US20030096221 Methods of identifying g-couple receptors associated with macrophage-thophic hiv, and diagnostic and therapeutic uses thereof
05/22/2003US20030096022 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095956 Methods of proliferating undifferentiated neural cells
05/22/2003US20030095897 Flow-controlled magnetic particle manipulation
05/22/2003US20030094384 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes
05/22/2003US20030094383 Determination of sample volume adequacy in biosensor devices